Hua Medicine (Shanghai) Profit Margin

The latest profit margin for HUMDF is 95.54% as of June 2026. That compares with -229.78% in the prior-year period — up 141.6% year over year. That is above the sector sector average of 13.2%. Investors often review this figure alongside Hua Medicine (Shanghai)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, HUMDF's profit margin moved from -229.78% to 95.54% — a 141.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Hua Medicine (Shanghai)'s valuation or profitability profile.

Against its sector companies, HUMDF currently prints 95.54% for profit margin, while the sector average sits near 13.2%. That is roughly 623.9% above the sector mean. Large gaps often invite a closer look at Hua Medicine (Shanghai)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Hua Medicine (Shanghai) converts resources into returns. At 95.54%, HUMDF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -229.78% in the prior-year period — up 141.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HUMDF's profit margin (95.54%), review year-over-year change from -229.78%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.